It usually takes one to three weeks for men to show symptoms of infection. It may not be possible to detect chlamydia if a test is performed less than 72 hours after exposure. Without treatment with an appropriate antibiotic it is unlikely that the body will clear itself of the infection. It is therefore possible to test positive for chlamydia from an exposure years earlier. As a consequence it is a leading cause of pelvic inflammatory disease and associated fertility difficulties.

It is very common, affecting around 1 in 10 young men and women; particularly women between the ages of 16 – 19 and men aged 19 – 24. Condoms can prevent it being spread, but unprotected sex, or a split in a condom, can pass it from partner to partner.

Answer: ATCC determines the infectious titer of Chlamydia cultures by the detection of inclusion bodies by immunofluorescence rather than the number of infectious units per preparation. The titer is reported as the detection of at least five inclusions per 11-mm round coverslip at the specified dilution and length of incubation. However, this procedure does not detect the endpoint of the infection. The TCID for Chlamydia is only a titer comparison from one tube at each dilution.

In pregnant women, there is evidence that untreated chlamydia can lead to premature delivery. Babies who are born to infected mothers can get chlamydia in their eyes and respiratory tracts. Chlamydia is a leading cause of early infant pneumonia and conjunctivitis (pink eye) in newborns.

In most "textbook" cases, primary herpes usually begins from two to three weeks after the virus enters the body. In some cases it has taken only a couple of days, while in others it can take much longer.

Women will need to supply a self-taken vulvo-vaginal swab (using the swab in the way you insert a tampon).

If you receive a positive result you will be asked to contact the office to arrange for free treatment. If your test is positive you will be treated with antibiotics. Normally it will be 4 tablets that you can take at once. We will also request information about your current or most recent sexual partners, this is so they can be contacted either by yourself or by us, this is to reduce the number of people carrying and transmitting Chlamydia.

Because Chlamydia often has no symptoms, the only way of knowing whether you or your partner have it for you both to be tested. Always use condoms with a new sexual partner, not only can this help prevent Chlamydia, but it is also a barrier against pregnancy and other sexually transmitted infections. If you are thinking about stopping using condoms with a regular partner, it is best that you both get a full check up before doing so.

Chlamydia is the most often reported bacterial STD in the United States. About 2.8 million Americans get chlamydia each year. Women are often re-infected if their sex partners are not treated.

Chlamydia is known as a "silent" disease because about 75 percent of infected women and about 50 percent of infected men have no symptoms. If symptoms do occur, they usually appear within one to three weeks after exposure.

If untreated, chlamydia can develop into serious reproductive and other health problems with both short-term and long-term effects. Like the disease itself, the damage is often "silent."

Chlamydia can be easily treated and cured with antibiotics. People with HIV and chlamydia should receive the same treatment as those who are HIV negative.

Staph bacteria, including MRSA, can cause skin infections that may look like a pimple or boil and can be red, swollen, painful, or have pus or other drainage. More serious infections may cause pneumonia, bloodstream infections, or surgical wound infections.

Up to 6 months. If there has been NO risk for 6 months prior to the test, the results are 99.9% accurate. People with HIV may be MOST infectious to others during this first six months.

Dual Antibiotic Treatment. Dual treatment with an antimicrobial effective against gonorrhea and chlamydia infections is based on theory and expert opinion rather than on evidence from RCTs. The balance between benefits and harms will vary with the prevalence of coinfection in each population. http://www.aafp.org/afp/20050701/bmj.